Q-line Biotech Limited
NSE: QLINE · Other · sector
₹541.60NSE close 2026-10-26
Key numbers
Market cap₹881 cr
Price₹541.60
52w high / low₹735 / ₹431
P/E15.6xSector median 14.4x
P/B3.8xSector median 1.7x
Book value₹141.3
Dividend yield–Sector median 0.37%
ROE24.2%Sector median 13.8%
ROCE40.0%Sector median 19.6%
OPM28.4%Sector median 10.4%
Debt / equity–Sector median 0.29x
EV/EBITDA8.3xSector median 8.4x
Interest cover4.7x
Current ratio1.64x
Sales growth 3y–Sector median +7.7%
Profit growth 3y–Sector median +16.6%
PEG–
Last 12 months to Mar 2026, Consolidated. "Sector median" = middle value of 688 companies in Other (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 4.7x in the last 12 months.
- Other income was 10% of net profit in the last 12 months.
- No dividend in the last 1 financial years.
- Price ₹541.60 on 2026-10-26: -26.3% from the 52-week high, +25.7% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹722.10 · low ₹468.50
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Mar 2026 |
|---|---|
| Revenue | 198 |
| EBITDA | 61 |
| OPM % | 30.9% |
| Other income | 3 |
| Net profit | 34 |
| EPS (₹) | 21.48 |
Consolidated figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY26 | TTM |
|---|---|---|
| Revenue | 342 | 342 |
| EBITDA | 97 | 97 |
| Net profit | 56 | 56 |
| EPS (₹) | 34.79 | 34.79 |
| Dividend / share (₹) | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Balance sheet
| ₹ cr | FY26 |
|---|---|
| Shareholders' equity | 230 |
| Cash & equivalents | 76 |
| Total assets | 559 |
| Fixed assets | 119 |
| Investments | 17 |
| Inventory | 95 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY26 |
|---|---|
| Cash from operations | 16 |
| Cash from investing | -29 |
| Cash from financing | 42 |
| Capex | 36 |
| Free cash flow | -20 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY26 |
|---|---|
| ROE % | 24.2% |
| ROCE % | 40.0% |
| Inventory days | 258 |
| Working capital days | 143 |
Peers in Other
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| TSFINV | ₹8,585 cr | 17.6x | 1.4x | 8.4% | 3.6% | 20.5% | +121.7% | 2.30% |
| KRISHANA | ₹6,339 cr | 39.9x | 11.3x | 41.6% | 23.2% | 12.6% | +95.7% | 0.05% |
| MARINE | ₹5,431 cr | 84.2x | 11.0x | 14.3% | 18.0% | 10.8% | +25.6% | 0.07% |
| ZOTA | ₹4,139 cr | – | 6.0x | -22.5% | -12.4% | -0.5% | +56.7% | 0.07% |
| AIMTRON | ₹3,319 cr | 71.7x | 17.1x | 28.0% | 31.8% | 21.8% | – | – |
| ACCORD | ₹2,984 cr | – | 261.7x | 12.4% | 12.0% | 2.4% | – | – |
| MONOLITH | ₹2,646 cr | 64.6x | 24.3x | 36.0% | 48.7% | 24.4% | – | – |
| UTSSAV | ₹2,390 cr | 40.2x | 14.1x | 43.4% | 54.7% | 7.9% | – | – |
| BETA | ₹2,200 cr | 40.6x | 5.0x | 16.4% | 17.0% | 20.8% | – | – |
| QLINE | ₹881 cr | 15.6x | 3.8x | 24.2% | 40.0% | 28.4% | – | – |
Business segments (FY26)
| Segment | Revenue | Share | EBIT | Margin |
|---|---|---|---|---|
| Sale of Product Manufactured | ₹230 cr | 67.4% | ₹115 cr | 50.1% |
| Sale of Traded Goods | ₹112 cr | 32.6% | ₹44 cr | 39.6% |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | |
| Industry | Other |
| Sub-industry | |
| Symbol | QLINE |
| BSE code | – |
| ISIN | INE1G2W01011 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-23 from NSE company filings (XBRL: Integrated Filing - Financials + financial results); price = NSE close 2026-10-26.